# CellCentric

**Source:** https://www.startuphub.ai/startups/cellcentric
**Profile type:** Startup

> A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

## About

CellCentric is a clinical-stage biotechnology company focused on developing inobrodib, a novel oral p300/CBP inhibitor, for the treatment of multiple myeloma. The company recently completed an oversubscribed $220 million Series D financing round, which will be used to advance the development of inobrodib.

## Key facts

- **Slug:** cellcentric
- **Website:** https://www.cellcentric.com/
- **Location:** Cambridge, England, United Kingdom
- **Founded:** 2003-01-01
- **Employees:** 53
- **Operating status:** Active
- **Total funding:** $375M
- **Sectors / tags:** Biotechnology, Pharmaceuticals, Healthcare, Biotech, Medical, Therapeutics, Drug Discovery, Clinical Trials, Oncology, Pharmaceutical
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/cellcentric/
  - Twitter: https://twitter.com/cellcentric

## Frequently asked

### What does CellCentric do?

CellCentric is a clinical-stage biotechnology company focused on developing inobrodib, a novel oral p300/CBP inhibitor, for the treatment of multiple myeloma. The company recently completed an oversubscribed $220 million Series D financing round, which will be used to advance the development of inobrodib.

### What is CellCentric's revenue?

StartupHub estimates CellCentric's annual revenue at $8.2M (range $4.4M to $22.8M, 68% confidence), based on comparable companies in the sector.

### What is CellCentric's valuation?

StartupHub estimates CellCentric's effective valuation at $1.5B (range $937.5M to $2.3B, 23% confidence), based on comparable companies in the sector.

### How much funding has CellCentric raised?

CellCentric has raised a total of $375M in funding. The most recent round on record is Series D.

### Where is CellCentric headquartered?

CellCentric is headquartered in Cambridge, England, United Kingdom.

### When was CellCentric founded?

CellCentric was founded in 2003.

### What industry does CellCentric operate in?

CellCentric operates in Biotechnology, Pharmaceuticals, Healthcare, Biotech, Medical, Therapeutics.

### How many employees does CellCentric have?

CellCentric has approximately 53 people on record.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "CellCentric",
          "item": "https://www.startuphub.ai/startups/cellcentric"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/cellcentric#webpage",
      "url": "https://www.startuphub.ai/startups/cellcentric",
      "name": "CellCentric - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of CellCentric. CellCentric is a startup founded in 2003, operating in Biotechnology and Pharmaceuticals. A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma. Headquartered in Cambridge, England, United Kingdom. The company has approximately 53 employees.",
      "dateModified": "2026-05-08T06:00:00.147+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/cellcentric#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/cellcentric#organization",
      "name": "CellCentric",
      "url": "https://www.cellcentric.com/",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/adcd45e8-7ea6-48e0-9de2-4ae61978dfcc-square.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/adcd45e8-7ea6-48e0-9de2-4ae61978dfcc-square.webp",
      "description": "This is the official profile of CellCentric. CellCentric is a startup founded in 2003, operating in Biotechnology and Pharmaceuticals. A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma. Headquartered in Cambridge, England, United Kingdom. The company has approximately 53 employees.",
      "sameAs": [
        "https://www.linkedin.com/company/cellcentric/",
        "https://twitter.com/cellcentric",
        "https://www.startuphub.ai/startups/cellcentric"
      ],
      "foundingDate": "2003-01-01",
      "numberOfEmployees": {
        "@type": "QuantitativeValue",
        "value": 53
      },
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Cambridge",
        "addressRegion": "England",
        "addressCountry": "GB"
      },
      "knowsAbout": [
        "Biotechnology",
        "Pharmaceuticals",
        "Healthcare",
        "Biotech",
        "Medical",
        "Therapeutics",
        "Drug Discovery",
        "Clinical Trials",
        "Oncology",
        "Pharmaceutical"
      ]
    },
    {
      "@type": "Product",
      "@id": "https://www.startuphub.ai/startups/cellcentric#profile-assessment",
      "name": "CellCentric - StartupHub.ai Profile Assessment",
      "url": "https://www.startuphub.ai/startups/cellcentric",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/adcd45e8-7ea6-48e0-9de2-4ae61978dfcc-square.webp",
      "category": "Biotechnology",
      "description": "This is the official profile of CellCentric. CellCentric is a startup founded in 2003, operating in Biotechnology and Pharmaceuticals. A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma. Headquartered in Cambridge, England, United Kingdom. The company has approximately 53 employees. Agent Readiness score: 33/100. Full audit: https://www.startuphub.ai/startups/cellcentric/agent-readiness",
      "brand": {
        "@type": "Brand",
        "name": "CellCentric"
      },
      "review": {
        "@type": "Review",
        "author": {
          "@type": "Organization",
          "name": "StartupHub.ai"
        },
        "datePublished": "2026-05-08",
        "name": "CellCentric - Profile Score 60/100",
        "reviewBody": "This is the official profile of CellCentric. CellCentric is a startup founded in 2003, operating in Biotechnology and Pharmaceuticals. A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma. Headquartered in Cambridge, England, United Kingdom. The company has approximately 53 employees. Agent Readiness score: 33/100. Full audit: https://www.startuphub.ai/startups/cellcentric/agent-readiness",
        "reviewRating": {
          "@type": "Rating",
          "ratingValue": 60,
          "bestRating": 100,
          "worstRating": 0
        }
      }
    }
  ]
}
```